Organon is a strong investment opportunity with a high yield, diversified portfolio, steady performance, and transformative ...

On Wednesday, Organon & Co (OGN) stock saw a modest uptick, ending the day at $15.61 which represents a slight increase of $0.03 or 0.19% from the prior close of $15.58. The stock opened at $15.58 and ...

The $1.2 billion Dermavant acquisition appears strategically acceptable but carries significant risks due to market ...

CWA Asset Management Group LLC acquired a new position in Organon & Co. (NYSE:OGN – Free Report) in the third quarter, ...

Despite announcing strong earnings, Organon & Co.'s ( NYSE:OGN ) stock was sluggish. We did some digging and found ...

On Tuesday, Organon & Co (OGN) stock saw a decline, ending the day at $16.46 which represents a decrease of $-0.46 or -2.72% from the prior close of $16.92. The stock opened at $16.74 and touched a ...

Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of Organon & Co (Symbol: OGN) were yielding above the 6% mark based on its quarterly dividend ...

Organon & Co. ( NYSE:OGN ) shareholders are probably feeling a little disappointed, since its shares fell 3.1% ...

Evercore ISI analyst Umer Raffat maintained a Buy rating on Organon (OGN – Research Report) today. The company’s shares closed ...

For the quarter ended September 2024, Organon (OGN) reported revenue of $1.58 billion, up 4.2% over the same period last year. EPS came in at $0.87, compared to $0.87 in the year-ago quarter.